TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 2 February 1, 2013
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings:
http://tf7.org/meetings.htm
_________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 2 February 1, 2013
(The next issue will be on February 18, 2013)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings:
http://tf7.org/meetings.htm
_________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1zmm7sb-pB7lfTuyEjrN0er/
Ahmad-Nejad P, Dempfle CE, Weiss C, Bugert P, Borggrefe M, Neumaier M (2012) The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events. Thromb Res 130:441-444.
http://www.ncbi.nlm.nih.gov/pubmed/22421107
Balia C, Petrini S, Cordazzo C, Cianchetti S, Neri T, Celi A, Pedrinelli R (2012) High glucose potentiates and renin-angiotensin blockade downregulates LPS-induced tissue factor expression in human mononuclear cells. Thromb Res 130:552-556.
http://www.ncbi.nlm.nih.gov/pubmed/22817879
Basavaraj MG, Olsen JO, Osterud B, Hansen JB (2012) Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Thromb Res 130:538-546.
http://www.ncbi.nlm.nih.gov/pubmed/22728024
Bolton-Maggs PH (2013) The rare inherited coagulation disorders. Pediatr Blood Cancer 60 Suppl 1:S37-40.
http://www.ncbi.nlm.nih.gov/pubmed/23109366
Chang JY, Chantrathammachart P, Monroe DM, Key NS (2012) Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitor. Thromb Res 130:e151-157.
http://www.ncbi.nlm.nih.gov/pubmed/22658294
Chen JS, Zhang B, Pan CZ, Ren L, Chen YD (2013) [Effects of monocyte chemotactic protein-3 on ICAM-1, VCAM-1, TF, and TFPI expression and apoptosis in human umbilical vein endothelial cells]. Nan Fang Yi Ke Da Xue Xue Bao 33:86-92.
http://www.ncbi.nlm.nih.gov/pubmed/23353163
Chen VM (2013) Tissue Factor De-encryption, Thrombus Formation, and Thiol-disulfide Exchange. Semin Thromb Hemost.
http://www.ncbi.nlm.nih.gov/pubmed/23325480
Chrysanthopoulou A, Mitroulis I, Kambas K, Skendros P, Kourtzelis I, Vradelis S, . . . Ritis K (2011) Tissue factor-thrombin signaling enhances the fibrotic activity of myofibroblasts in systemic sclerosis through up-regulation of endothelin receptor A. Arthritis Rheum 63:3586-3597.
http://www.ncbi.nlm.nih.gov/pubmed/21834070
Cirillo P, Di Palma V, Maresca F, Pacifico F, Ziviello F, Bevilacqua M, . . . Chiariello M (2012) The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle. Thromb Res 130:403-408.
http://www.ncbi.nlm.nih.gov/pubmed/22726553
Cochrane TI (2013) Off-protocol access to study therapies. Top Stroke Rehabil 20:1-4.
http://www.ncbi.nlm.nih.gov/pubmed/23340066
de Oliveira Ada S, Lima LG, Mariano-Oliveira A, Machado DE, Nasciutti LE, Andersen JF, . . . Monteiro RQ (2012) Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma. Thromb Res 130:e163-170.
http://www.ncbi.nlm.nih.gov/pubmed/22683021
Defrates SR, McDonagh KT, Adams VR (2013) The Reversal of Inhibitors in Congenital Hemophilia. Pharmacotherapy.
http://www.ncbi.nlm.nih.gov/pubmed/23355059
Divani AA, Luo X, Brandy KR, Meyer RM, Joseph MS, Flaherty JD, . . . Datta YH (2012) Oral versus vaginal combined hormonal contraceptives' effect on coagulation and inflammatory biomarkers among young adult women. Clin Appl Thromb Hemost 18:487-494.
http://www.ncbi.nlm.nih.gov/pubmed/22431858
Eleftheriou D, Ganesan V, Hong Y, Klein NJ, Brogan PA (2012) Endothelial injury in childhood stroke with cerebral arteriopathy: a cross-sectional study. Neurology 79:2089-2096.
http://www.ncbi.nlm.nih.gov/pubmed/23077025
Fattorini A, Pattarini E, Vigano S, Crippa L, D'Angelo A (2012) Use of INR calibrator plasmas in the routine coagulation laboratory: a study of two thrombolastin reagents. Thromb Res 130:e158-162.
http://www.ncbi.nlm.nih.gov/pubmed/22682443
Figueras J, Monasterio J, Lidon RM, Sambola A, Garcia-Dorado D (2012) Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction. Thromb Res 130:458-462.
http://www.ncbi.nlm.nih.gov/pubmed/22424853
Franks Z, Campbell RA, Vieira de Abreu A, Holloway JT, Marvin JE, Kraemer BF, . . . Rondina MT (2013) Methicillin-resistant Staphylococcus aureus - induced thrombo-inflammatory response is reduced with timely antibiotic administration. Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23348831
Fries D (2013) The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. Transfusion 53 Suppl 1:91S-95S.
http://www.ncbi.nlm.nih.gov/pubmed/23301979
Gao Y, Lv L, Liu S, Ma G, Su Y (2013) Elevated levels of thrombin-generating microparticles in stored red blood cells. Vox Sang.
http://www.ncbi.nlm.nih.gov/pubmed/23347295
Guglielmone HA, Nunez-Montoya SC, Agnese AM, Pellizas CG, Cabrera JL, Donadio AC (2012) Quercetin 3,7,3',4'-tetrasulphated isolated from Flaveria bidentis inhibits tissue factor expression in human monocyte. Phytomedicine 19:1068-1071.
http://www.ncbi.nlm.nih.gov/pubmed/22819449
Guo Y, Lip GY, Apostolakis S (2012) Inflammation in atrial fibrillation. J Am Coll Cardiol 60:2263-2270.
http://www.ncbi.nlm.nih.gov/pubmed/23194937
Guth MC, Kaufner L, Kleber C, von Heymann C (2012) [Therapy of trauma-induced coagulopathy - what is the evidence?]. Anasthesiol Intensivmed Notfallmed Schmerzther 47:528-539; quiz 540.
http://www.ncbi.nlm.nih.gov/pubmed/22968981
Halvorsen B, Dahl TB, Aukrust P (2012) Visfatin/NAMPT - a hot spot in thrombosis? Thromb Res 130:289-290.
http://www.ncbi.nlm.nih.gov/pubmed/22809845
Hao J, Li W, Zou P, Li Q, Xia L, You Y (2009) Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. J Huazhong Univ Sci Technolog Med Sci 29:697-700.
http://www.ncbi.nlm.nih.gov/pubmed/20037809
Hewing B, Parathath S, Mai CK, Fiel MI, Guo L, Fisher EA (2013) Rapid regression of atherosclerosis with MTP inhibitor treatment. Atherosclerosis.
http://www.ncbi.nlm.nih.gov/pubmed/23332773
Hilbert P, Hofmann GO, zur Nieden K, Teichmann J, Jakubetz J, Stuttmann R (2012) [Coagulation management of trauma patients with unstabile circulation : establishment of a hemoglobin-oriented standard operating procedure]. Anaesthesist 61:703-710.
http://www.ncbi.nlm.nih.gov/pubmed/22847558
Hus I, Sokolowska B, Walter-Croneck A, Chrapko M, Nowaczynska A, Dmoszynska A (2013) Assessment of plasma prothrombotic factors in patients with Buerger's disease. Blood Coagul Fibrinolysis 24:133-139.
http://www.ncbi.nlm.nih.gov/pubmed/23358197
Khurana S, Margamuljana L, Joseph C, Schouteden S, Buckley SM, Verfaillie CM (2013) Glypican-3 mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/23327927
Kidd L, Mackman N (2013) Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia. J Vet Emerg Crit Care (San Antonio) 23:3-13.
http://www.ncbi.nlm.nih.gov/pubmed/23356703
Kim SH, Park YS, Kwon KH, Lee JH, Kim KC, Yoo MC (2012) Surgery in patients with congenital factor VII deficiency: A single center experience. Korean J Hematol 47:281-285.
http://www.ncbi.nlm.nih.gov/pubmed/23320007
Knappe S, Gorczyca ME, Jilma B, Derhaschnig U, Hartmann R, Palige M, . . . Dockal M (2013) Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood. Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23348798
Lambrianides A, Turner-Stokes T, Pericleous C, Ehsanullah J, Papadimitraki E, Poulton K, . . . Giles I (2011) Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis. Arthritis Rheum 63:3512-3521.
http://www.ncbi.nlm.nih.gov/pubmed/21739425
Lapecorella M, Napolitano M, Lucchesi A, Pisani F, Clemente K, Rizza V, . . . Di Cocco P (2012) Management of kidney transplantation in a factor VII-deficient patient: case report. Transplant Proc 44:2033-2035.
http://www.ncbi.nlm.nih.gov/pubmed/22974900
Lelakowski J, Domagala TB, Rydlewska A, Januszek R, Kotula-Horowitz K, Majewski J, . . . Malecka B (2012) Relationship between changes in selected thrombotic and inflammatory factors, echocardiographic parameters and the incidence of venous thrombosis after pacemaker implantation based on our own observations. Arch Med Sci 8:1027-1034.
http://www.ncbi.nlm.nih.gov/pubmed/23319977
Levi M, van der Poll T, Schultz M (2012) Infection and inflammation as risk factors for thrombosis and atherosclerosis. Semin Thromb Hemost 38:506-514.
http://www.ncbi.nlm.nih.gov/pubmed/22399308
Li M, Zheng F, Jin Y, Wang M, Zhu L, Yang L (2013) Double heterozygous mutations Gln100Leu and His348Gln of the F7 gene in a patient with factor VII deficiency. Blood Coagul Fibrinolysis 24:199-201.
http://www.ncbi.nlm.nih.gov/pubmed/23358202
Ma G, Liu F, Lv L, Gao Y, Su Y (2013) Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia. Ann Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/23344645
Maegele M (2013) Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options. Transfusion 53 Suppl 1:28S-37S.
http://www.ncbi.nlm.nih.gov/pubmed/23301970
Manne BK, Getz TM, Hughes CE, Alshehri O, Dangelmaier C, Naik U, . . . Kunapuli SP (2013) Fucoidan is a novel platelet agonist for the CLEC-2 receptor. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23341451
Maruyama K, Morishita E, Yuno T, Sekiya A, Asakura H, Ohtake S, Yachie A (2012) Carbon monoxide (CO)-releasing molecule-derived CO regulates tissue factor and plasminogen activator inhibitor type 1 in human endothelial cells. Thromb Res 130:e188-193.
http://www.ncbi.nlm.nih.gov/pubmed/22819264
Neufeld EJ, Saxena K, Kessler CM, Cooper DL (2013) Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: The experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008). Pediatr Blood Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/23335449
Oku K, Amengual O, Atsumi T (2012) Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome. Eur J Clin Invest 42:1126-1135.
http://www.ncbi.nlm.nih.gov/pubmed/22784367
Okuda M, Taniguchi T, Takamiya O (2012) Properties of a recombinant bovine tissue factor expressed by Silkworm pupae and its performance as an Owren-type prothrombin time reagent for warfarin monitoring. Thromb Res 130:520-527.
http://www.ncbi.nlm.nih.gov/pubmed/22698434
Pamuk BO, Sari I, Selcuk S, Gokce G, Kozaci DL (2013) Evaluation of circulating endothelial biomarkers in familial Mediterranean fever. Rheumatol Int.
http://www.ncbi.nlm.nih.gov/pubmed/23358733
Pedersen A, Hanson E, Olsson S, Stanne TM, Blomstrand C, Melander O, . . . Jern C (2012) TFPI gene variation and ischemic stroke. Thromb Res 130:565-567.
http://www.ncbi.nlm.nih.gov/pubmed/22749962
Peraramelli S, Thomassen S, Heinzmann A, Rosing J, Hackeng TM, Hartmann R, . . . Dockal M (2013) Direct inhibition of factor VIIa by TFPI and TFPI constructs. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23347185
Petricevic M, Biocina B, Konosic S, Burcar I (2012) Haemostatic management in high-risk cardiac surgery: a role of recombinant factor VIIa (NovoSeven RT). Eur J Cardiothorac Surg 42:606-607.
http://www.ncbi.nlm.nih.gov/pubmed/22504897
Petricevic M, Biocina B, Milicic D (2012) Hemostatic management in complex aortic surgery: a role for multiple electrode aggregometry and modified rotational thromboelastometry. J Thorac Cardiovasc Surg 144:1534-1535.
http://www.ncbi.nlm.nih.gov/pubmed/23140969
Pettersen AA, Arnesen H, Opstad TB, Bratseth V, Seljeflot I (2012) Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease. Thromb Res 130:424-428.
http://www.ncbi.nlm.nih.gov/pubmed/22795340
Prinz N, Clemens N, Canisius A, Lackner KJ (2013) Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells. Lessons from the antiphospholipid syndrome. Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23328933
Qin YY, Gong W, Weng MZ, Li JY, Quan ZW (2012) [The role of tissue factor pathway inhibitor-2 gene in gallbaldder cancer]. Zhonghua Wai Ke Za Zhi 50:1099-1103.
http://www.ncbi.nlm.nih.gov/pubmed/23336488
Reichman-Warmusz E, Kurek J, Gabriel A, Brzozowa M, Bula G, Helewski K, . . . Wojnicz R (2012) Tissue hemostasis and chronic inflammation in colon biopsies of patients with inflammatory bowel disease. Pathol Res Pract 208:553-556.
http://www.ncbi.nlm.nih.gov/pubmed/22842215
Roedel EK, Schwarz E, Kanse SM (2013) The Factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2). J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23341458
Santos MJ, Carmona-Fernandes D, Canhao H, Canas da Silva J, Fonseca JE, Gil V (2012) Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk. PLoS One 7:e44668.
http://www.ncbi.nlm.nih.gov/pubmed/22962622
Sebag SC, Bastarache JA, Ware LB (2013) Mechanical stretch inhibits lipopolysaccharide (LPS)-induced KC and tissue factor (TF) expression while increasing procoagulant activity in murine lung epithelial cells. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23362270
Shen CY, Fu LS, Lin HK, Han SM, Wang JD (2012) Macrohematuria as initial presentation in a girl with factor VIII and factor IX inhibitors associated with systemic lupus erythematosus. J Pediatr Hematol Oncol 34:e344-345.
http://www.ncbi.nlm.nih.gov/pubmed/23018565
Shrivastava S, Ma L, Tham EL, McVey J, Chen D, Dorling A (2013) Protease activated receptor-2 signalling by tissue factor on dendritic cells suppresses antigen-specific CD4(+) T cell priming. Immunology.
http://www.ncbi.nlm.nih.gov/pubmed/23347132
Stavik B, Tinholt M, Sletten M, Skretting G, Sandset PM, Iversen N (2013) TFPIalpha and TFPIbeta are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity. J Hematol Oncol 6:5.
http://www.ncbi.nlm.nih.gov/pubmed/23320987
Tobin JM, Varon AJ (2012) Review article: update in trauma anesthesiology: perioperative resuscitation management. Anesth Analg 115:1326-1333.
http://www.ncbi.nlm.nih.gov/pubmed/22763906
Wang W, Sun L, Deng Y, Tang J (2013) Synergistic effects of anti-high-mobility group box 1 and anti-TNFalpha antibodies on D-GalN/LPS-induced acute liver failure. FEBS J.
http://www.ncbi.nlm.nih.gov/pubmed/23331758
Weitz IC, Razavi P, Rochanda L, Zwicker J, Furie B, Manly D, . . . Liebman HA (2012) Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation. Thromb Res 130:361-368.
http://www.ncbi.nlm.nih.gov/pubmed/22542362
Welsh J, Smith JD, Yates KR, Greenman J, Maraveyas A, Madden LA (2012) Tissue factor expression determines tumour cell coagulation kinetics. Int J Lab Hematol 34:396-402.
http://www.ncbi.nlm.nih.gov/pubmed/22348286
Wygrecka M, Zakrzewicz D, Taborski B, Didiasova M, Kwapiszewska G, Preissner KT, Markart P (2012) TGF-beta1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner. Am J Respir Cell Mol Biol 47:614-627.
http://www.ncbi.nlm.nih.gov/pubmed/22771387
Yu YJ, Li YM, Hou XD, Guo C, Cao N, Jiao ZY (2012) Effect of tissue factor on invasion inhibition and apoptosis inducing effect of oxaliplatin in human gastric cancer cell. Asian Pac J Cancer Prev 13:1845-1849.
http://www.ncbi.nlm.nih.gov/pubmed/22901134
Zheng Y, Liu X, Guo SW (2012) Therapeutic potential of andrographolide for treating endometriosis. Hum Reprod 27:1300-1313.
http://www.ncbi.nlm.nih.gov/pubmed/22402211
Zhou Q, Xiong Y, Chen Y, Du Y, Zhang J, Mu J, . . . Li X (2012) Effects of tissue factor pathway inhibitor-2 expression on biological behavior of BeWo and JEG-3 cell lines. Clin Appl Thromb Hemost 18:526-533.
http://www.ncbi.nlm.nih.gov/pubmed/22203034
Zhou W, Zorn M, Nawroth P, Butehorn U, Perzborn E, Heitmeier S, Veltkamp R (2013) Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With Rivaroxaban. Stroke.
http://www.ncbi.nlm.nih.gov/pubmed/23339956
__________________________________________________________
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1zmm7sb-pB7lfTuyEjrN0er/
Ahmad-Nejad P, Dempfle CE, Weiss C, Bugert P, Borggrefe M, Neumaier M (2012) The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events. Thromb Res 130:441-444.
http://www.ncbi.nlm.nih.gov/pubmed/22421107
Balia C, Petrini S, Cordazzo C, Cianchetti S, Neri T, Celi A, Pedrinelli R (2012) High glucose potentiates and renin-angiotensin blockade downregulates LPS-induced tissue factor expression in human mononuclear cells. Thromb Res 130:552-556.
http://www.ncbi.nlm.nih.gov/pubmed/22817879
Basavaraj MG, Olsen JO, Osterud B, Hansen JB (2012) Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Thromb Res 130:538-546.
http://www.ncbi.nlm.nih.gov/pubmed/22728024
Bolton-Maggs PH (2013) The rare inherited coagulation disorders. Pediatr Blood Cancer 60 Suppl 1:S37-40.
http://www.ncbi.nlm.nih.gov/pubmed/23109366
Chang JY, Chantrathammachart P, Monroe DM, Key NS (2012) Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitor. Thromb Res 130:e151-157.
http://www.ncbi.nlm.nih.gov/pubmed/22658294
Chen JS, Zhang B, Pan CZ, Ren L, Chen YD (2013) [Effects of monocyte chemotactic protein-3 on ICAM-1, VCAM-1, TF, and TFPI expression and apoptosis in human umbilical vein endothelial cells]. Nan Fang Yi Ke Da Xue Xue Bao 33:86-92.
http://www.ncbi.nlm.nih.gov/pubmed/23353163
Chen VM (2013) Tissue Factor De-encryption, Thrombus Formation, and Thiol-disulfide Exchange. Semin Thromb Hemost.
http://www.ncbi.nlm.nih.gov/pubmed/23325480
Chrysanthopoulou A, Mitroulis I, Kambas K, Skendros P, Kourtzelis I, Vradelis S, . . . Ritis K (2011) Tissue factor-thrombin signaling enhances the fibrotic activity of myofibroblasts in systemic sclerosis through up-regulation of endothelin receptor A. Arthritis Rheum 63:3586-3597.
http://www.ncbi.nlm.nih.gov/pubmed/21834070
Cirillo P, Di Palma V, Maresca F, Pacifico F, Ziviello F, Bevilacqua M, . . . Chiariello M (2012) The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle. Thromb Res 130:403-408.
http://www.ncbi.nlm.nih.gov/pubmed/22726553
Cochrane TI (2013) Off-protocol access to study therapies. Top Stroke Rehabil 20:1-4.
http://www.ncbi.nlm.nih.gov/pubmed/23340066
de Oliveira Ada S, Lima LG, Mariano-Oliveira A, Machado DE, Nasciutti LE, Andersen JF, . . . Monteiro RQ (2012) Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma. Thromb Res 130:e163-170.
http://www.ncbi.nlm.nih.gov/pubmed/22683021
Defrates SR, McDonagh KT, Adams VR (2013) The Reversal of Inhibitors in Congenital Hemophilia. Pharmacotherapy.
http://www.ncbi.nlm.nih.gov/pubmed/23355059
Divani AA, Luo X, Brandy KR, Meyer RM, Joseph MS, Flaherty JD, . . . Datta YH (2012) Oral versus vaginal combined hormonal contraceptives' effect on coagulation and inflammatory biomarkers among young adult women. Clin Appl Thromb Hemost 18:487-494.
http://www.ncbi.nlm.nih.gov/pubmed/22431858
Eleftheriou D, Ganesan V, Hong Y, Klein NJ, Brogan PA (2012) Endothelial injury in childhood stroke with cerebral arteriopathy: a cross-sectional study. Neurology 79:2089-2096.
http://www.ncbi.nlm.nih.gov/pubmed/23077025
Fattorini A, Pattarini E, Vigano S, Crippa L, D'Angelo A (2012) Use of INR calibrator plasmas in the routine coagulation laboratory: a study of two thrombolastin reagents. Thromb Res 130:e158-162.
http://www.ncbi.nlm.nih.gov/pubmed/22682443
Figueras J, Monasterio J, Lidon RM, Sambola A, Garcia-Dorado D (2012) Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction. Thromb Res 130:458-462.
http://www.ncbi.nlm.nih.gov/pubmed/22424853
Franks Z, Campbell RA, Vieira de Abreu A, Holloway JT, Marvin JE, Kraemer BF, . . . Rondina MT (2013) Methicillin-resistant Staphylococcus aureus - induced thrombo-inflammatory response is reduced with timely antibiotic administration. Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23348831
Fries D (2013) The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. Transfusion 53 Suppl 1:91S-95S.
http://www.ncbi.nlm.nih.gov/pubmed/23301979
Gao Y, Lv L, Liu S, Ma G, Su Y (2013) Elevated levels of thrombin-generating microparticles in stored red blood cells. Vox Sang.
http://www.ncbi.nlm.nih.gov/pubmed/23347295
Guglielmone HA, Nunez-Montoya SC, Agnese AM, Pellizas CG, Cabrera JL, Donadio AC (2012) Quercetin 3,7,3',4'-tetrasulphated isolated from Flaveria bidentis inhibits tissue factor expression in human monocyte. Phytomedicine 19:1068-1071.
http://www.ncbi.nlm.nih.gov/pubmed/22819449
Guo Y, Lip GY, Apostolakis S (2012) Inflammation in atrial fibrillation. J Am Coll Cardiol 60:2263-2270.
http://www.ncbi.nlm.nih.gov/pubmed/23194937
Guth MC, Kaufner L, Kleber C, von Heymann C (2012) [Therapy of trauma-induced coagulopathy - what is the evidence?]. Anasthesiol Intensivmed Notfallmed Schmerzther 47:528-539; quiz 540.
http://www.ncbi.nlm.nih.gov/pubmed/22968981
Halvorsen B, Dahl TB, Aukrust P (2012) Visfatin/NAMPT - a hot spot in thrombosis? Thromb Res 130:289-290.
http://www.ncbi.nlm.nih.gov/pubmed/22809845
Hao J, Li W, Zou P, Li Q, Xia L, You Y (2009) Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. J Huazhong Univ Sci Technolog Med Sci 29:697-700.
http://www.ncbi.nlm.nih.gov/pubmed/20037809
Hewing B, Parathath S, Mai CK, Fiel MI, Guo L, Fisher EA (2013) Rapid regression of atherosclerosis with MTP inhibitor treatment. Atherosclerosis.
http://www.ncbi.nlm.nih.gov/pubmed/23332773
Hilbert P, Hofmann GO, zur Nieden K, Teichmann J, Jakubetz J, Stuttmann R (2012) [Coagulation management of trauma patients with unstabile circulation : establishment of a hemoglobin-oriented standard operating procedure]. Anaesthesist 61:703-710.
http://www.ncbi.nlm.nih.gov/pubmed/22847558
Hus I, Sokolowska B, Walter-Croneck A, Chrapko M, Nowaczynska A, Dmoszynska A (2013) Assessment of plasma prothrombotic factors in patients with Buerger's disease. Blood Coagul Fibrinolysis 24:133-139.
http://www.ncbi.nlm.nih.gov/pubmed/23358197
Khurana S, Margamuljana L, Joseph C, Schouteden S, Buckley SM, Verfaillie CM (2013) Glypican-3 mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/23327927
Kidd L, Mackman N (2013) Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia. J Vet Emerg Crit Care (San Antonio) 23:3-13.
http://www.ncbi.nlm.nih.gov/pubmed/23356703
Kim SH, Park YS, Kwon KH, Lee JH, Kim KC, Yoo MC (2012) Surgery in patients with congenital factor VII deficiency: A single center experience. Korean J Hematol 47:281-285.
http://www.ncbi.nlm.nih.gov/pubmed/23320007
Knappe S, Gorczyca ME, Jilma B, Derhaschnig U, Hartmann R, Palige M, . . . Dockal M (2013) Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood. Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23348798
Lambrianides A, Turner-Stokes T, Pericleous C, Ehsanullah J, Papadimitraki E, Poulton K, . . . Giles I (2011) Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis. Arthritis Rheum 63:3512-3521.
http://www.ncbi.nlm.nih.gov/pubmed/21739425
Lapecorella M, Napolitano M, Lucchesi A, Pisani F, Clemente K, Rizza V, . . . Di Cocco P (2012) Management of kidney transplantation in a factor VII-deficient patient: case report. Transplant Proc 44:2033-2035.
http://www.ncbi.nlm.nih.gov/pubmed/22974900
Lelakowski J, Domagala TB, Rydlewska A, Januszek R, Kotula-Horowitz K, Majewski J, . . . Malecka B (2012) Relationship between changes in selected thrombotic and inflammatory factors, echocardiographic parameters and the incidence of venous thrombosis after pacemaker implantation based on our own observations. Arch Med Sci 8:1027-1034.
http://www.ncbi.nlm.nih.gov/pubmed/23319977
Levi M, van der Poll T, Schultz M (2012) Infection and inflammation as risk factors for thrombosis and atherosclerosis. Semin Thromb Hemost 38:506-514.
http://www.ncbi.nlm.nih.gov/pubmed/22399308
Li M, Zheng F, Jin Y, Wang M, Zhu L, Yang L (2013) Double heterozygous mutations Gln100Leu and His348Gln of the F7 gene in a patient with factor VII deficiency. Blood Coagul Fibrinolysis 24:199-201.
http://www.ncbi.nlm.nih.gov/pubmed/23358202
Ma G, Liu F, Lv L, Gao Y, Su Y (2013) Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia. Ann Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/23344645
Maegele M (2013) Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options. Transfusion 53 Suppl 1:28S-37S.
http://www.ncbi.nlm.nih.gov/pubmed/23301970
Manne BK, Getz TM, Hughes CE, Alshehri O, Dangelmaier C, Naik U, . . . Kunapuli SP (2013) Fucoidan is a novel platelet agonist for the CLEC-2 receptor. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23341451
Maruyama K, Morishita E, Yuno T, Sekiya A, Asakura H, Ohtake S, Yachie A (2012) Carbon monoxide (CO)-releasing molecule-derived CO regulates tissue factor and plasminogen activator inhibitor type 1 in human endothelial cells. Thromb Res 130:e188-193.
http://www.ncbi.nlm.nih.gov/pubmed/22819264
Neufeld EJ, Saxena K, Kessler CM, Cooper DL (2013) Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: The experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008). Pediatr Blood Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/23335449
Oku K, Amengual O, Atsumi T (2012) Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome. Eur J Clin Invest 42:1126-1135.
http://www.ncbi.nlm.nih.gov/pubmed/22784367
Okuda M, Taniguchi T, Takamiya O (2012) Properties of a recombinant bovine tissue factor expressed by Silkworm pupae and its performance as an Owren-type prothrombin time reagent for warfarin monitoring. Thromb Res 130:520-527.
http://www.ncbi.nlm.nih.gov/pubmed/22698434
Pamuk BO, Sari I, Selcuk S, Gokce G, Kozaci DL (2013) Evaluation of circulating endothelial biomarkers in familial Mediterranean fever. Rheumatol Int.
http://www.ncbi.nlm.nih.gov/pubmed/23358733
Pedersen A, Hanson E, Olsson S, Stanne TM, Blomstrand C, Melander O, . . . Jern C (2012) TFPI gene variation and ischemic stroke. Thromb Res 130:565-567.
http://www.ncbi.nlm.nih.gov/pubmed/22749962
Peraramelli S, Thomassen S, Heinzmann A, Rosing J, Hackeng TM, Hartmann R, . . . Dockal M (2013) Direct inhibition of factor VIIa by TFPI and TFPI constructs. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23347185
Petricevic M, Biocina B, Konosic S, Burcar I (2012) Haemostatic management in high-risk cardiac surgery: a role of recombinant factor VIIa (NovoSeven RT). Eur J Cardiothorac Surg 42:606-607.
http://www.ncbi.nlm.nih.gov/pubmed/22504897
Petricevic M, Biocina B, Milicic D (2012) Hemostatic management in complex aortic surgery: a role for multiple electrode aggregometry and modified rotational thromboelastometry. J Thorac Cardiovasc Surg 144:1534-1535.
http://www.ncbi.nlm.nih.gov/pubmed/23140969
Pettersen AA, Arnesen H, Opstad TB, Bratseth V, Seljeflot I (2012) Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease. Thromb Res 130:424-428.
http://www.ncbi.nlm.nih.gov/pubmed/22795340
Prinz N, Clemens N, Canisius A, Lackner KJ (2013) Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells. Lessons from the antiphospholipid syndrome. Thromb Haemost 109.
http://www.ncbi.nlm.nih.gov/pubmed/23328933
Qin YY, Gong W, Weng MZ, Li JY, Quan ZW (2012) [The role of tissue factor pathway inhibitor-2 gene in gallbaldder cancer]. Zhonghua Wai Ke Za Zhi 50:1099-1103.
http://www.ncbi.nlm.nih.gov/pubmed/23336488
Reichman-Warmusz E, Kurek J, Gabriel A, Brzozowa M, Bula G, Helewski K, . . . Wojnicz R (2012) Tissue hemostasis and chronic inflammation in colon biopsies of patients with inflammatory bowel disease. Pathol Res Pract 208:553-556.
http://www.ncbi.nlm.nih.gov/pubmed/22842215
Roedel EK, Schwarz E, Kanse SM (2013) The Factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2). J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23341458
Santos MJ, Carmona-Fernandes D, Canhao H, Canas da Silva J, Fonseca JE, Gil V (2012) Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk. PLoS One 7:e44668.
http://www.ncbi.nlm.nih.gov/pubmed/22962622
Sebag SC, Bastarache JA, Ware LB (2013) Mechanical stretch inhibits lipopolysaccharide (LPS)-induced KC and tissue factor (TF) expression while increasing procoagulant activity in murine lung epithelial cells. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23362270
Shen CY, Fu LS, Lin HK, Han SM, Wang JD (2012) Macrohematuria as initial presentation in a girl with factor VIII and factor IX inhibitors associated with systemic lupus erythematosus. J Pediatr Hematol Oncol 34:e344-345.
http://www.ncbi.nlm.nih.gov/pubmed/23018565
Shrivastava S, Ma L, Tham EL, McVey J, Chen D, Dorling A (2013) Protease activated receptor-2 signalling by tissue factor on dendritic cells suppresses antigen-specific CD4(+) T cell priming. Immunology.
http://www.ncbi.nlm.nih.gov/pubmed/23347132
Stavik B, Tinholt M, Sletten M, Skretting G, Sandset PM, Iversen N (2013) TFPIalpha and TFPIbeta are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity. J Hematol Oncol 6:5.
http://www.ncbi.nlm.nih.gov/pubmed/23320987
Tobin JM, Varon AJ (2012) Review article: update in trauma anesthesiology: perioperative resuscitation management. Anesth Analg 115:1326-1333.
http://www.ncbi.nlm.nih.gov/pubmed/22763906
Wang W, Sun L, Deng Y, Tang J (2013) Synergistic effects of anti-high-mobility group box 1 and anti-TNFalpha antibodies on D-GalN/LPS-induced acute liver failure. FEBS J.
http://www.ncbi.nlm.nih.gov/pubmed/23331758
Weitz IC, Razavi P, Rochanda L, Zwicker J, Furie B, Manly D, . . . Liebman HA (2012) Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation. Thromb Res 130:361-368.
http://www.ncbi.nlm.nih.gov/pubmed/22542362
Welsh J, Smith JD, Yates KR, Greenman J, Maraveyas A, Madden LA (2012) Tissue factor expression determines tumour cell coagulation kinetics. Int J Lab Hematol 34:396-402.
http://www.ncbi.nlm.nih.gov/pubmed/22348286
Wygrecka M, Zakrzewicz D, Taborski B, Didiasova M, Kwapiszewska G, Preissner KT, Markart P (2012) TGF-beta1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner. Am J Respir Cell Mol Biol 47:614-627.
http://www.ncbi.nlm.nih.gov/pubmed/22771387
Yu YJ, Li YM, Hou XD, Guo C, Cao N, Jiao ZY (2012) Effect of tissue factor on invasion inhibition and apoptosis inducing effect of oxaliplatin in human gastric cancer cell. Asian Pac J Cancer Prev 13:1845-1849.
http://www.ncbi.nlm.nih.gov/pubmed/22901134
Zheng Y, Liu X, Guo SW (2012) Therapeutic potential of andrographolide for treating endometriosis. Hum Reprod 27:1300-1313.
http://www.ncbi.nlm.nih.gov/pubmed/22402211
Zhou Q, Xiong Y, Chen Y, Du Y, Zhang J, Mu J, . . . Li X (2012) Effects of tissue factor pathway inhibitor-2 expression on biological behavior of BeWo and JEG-3 cell lines. Clin Appl Thromb Hemost 18:526-533.
http://www.ncbi.nlm.nih.gov/pubmed/22203034
Zhou W, Zorn M, Nawroth P, Butehorn U, Perzborn E, Heitmeier S, Veltkamp R (2013) Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With Rivaroxaban. Stroke.
http://www.ncbi.nlm.nih.gov/pubmed/23339956
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
